Vyome (NASDAQ:HIND) Issues Earnings Results

Vyome (NASDAQ:HIND) announced its earnings results on Wednesday. The company reported ($0.10) earnings per share for the quarter, Zacks reports.

Vyome Stock Performance

Shares of HIND stock opened at $2.22 on Thursday. The firm has a market capitalization of $15.58 million, a price-to-earnings ratio of -0.18 and a beta of 1.48. Vyome has a one year low of $1.75 and a one year high of $18.60. The company has a 50 day moving average price of $2.17 and a 200 day moving average price of $2.31.

Institutional Trading of Vyome

A hedge fund recently bought a new stake in Vyome stock. Millennium Management LLC acquired a new position in Vyome Holdings, Inc. (NASDAQ:HIND) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 45,144 shares of the company’s stock, valued at approximately $155,000. Millennium Management LLC owned 0.80% of Vyome at the end of the most recent reporting period. 22.06% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Vyome in a research report on Wednesday, July 29th. Litchfield Hills Research started coverage on shares of Vyome in a research note on Monday, May 4th. They issued a “buy” rating for the company. Finally, Zacks Research upgraded Vyome to a “hold” rating in a report on Wednesday, May 6th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $15.00.

About Vyome

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.